Skip to content
Search

Latest Stories

Human case of bird flu confirmed in West Midlands

Human case of bird flu
Human case of avian flu confirmed in West Midlands

Despite this confirmed case, the risk of bird flu to the general public remains very low- says Professor Susan Hopkins

The UK Health Security Agency (UKHSA) has confirmed a case of avian influenza A(H5N1), commonly known as avian flu or bird flu, in a person from the West Midlands.

The affected person was admitted to a High Consequence Infectious Disease (HCID) unit and is reported to be doing well.


According to UKHSA, the person acquired the infection after prolonged close contact with infected birds on a farm.

Despite this confirmed case, Professor Susan Hopkins, chief medical adviser at UKHSA, reassured the public that the risk of avian flu to the general public remains “very low.”

She acknowledged the potential for spillover infections from birds to humans and emphasised that robust systems are in place to detect cases early and take necessary action.

She also confirmed no evidence of onward transmission from this case but urged people to avoid touching sick or dead birds and to report suspected cases.

The case was detected after an outbreak of avian influenza(H5N1) in a flock of birds was identified, prompting the UKHSA to conduct routine monitoring of individuals who had been in close contact with the infected birds.

The infected birds were found carrying the DI.2 genotype of the virus, which is circulating among UK birds this season.

UKHSA has been tracing all individuals who may have been exposed to the confirmed case and those at highest risk have been offered antiviral treatment to prevent potential infection.

Measures to contain the outbreak

Christine Middlemiss, the UK’s chief veterinary officer, emphasised that while avian influenza is highly contagious among birds, human cases remain very rare.

She said that all infected birds at the site have been humanely culled, and the premises are undergoing cleansing and disinfection under strict biosecurity protocols to contain the spread of the disease.

Middlemiss also highlighted the growing number of bird flu cases in both commercial and backyard flocks across the country, stressing the importance of stringent biosecurity measures when keeping animals.

Andrew Gwynne, minister for public health and prevention, assured the public that the government is closely monitoring the situation.

“The risk of wider or onward transmission is very low, however the UK remains prepared and ready to respond to any current and future health threats,” Gwynne stated.

As part of its preparedness plan, the government has added the H5 vaccine, which offers protection against avian influenza, to its national stockpile.

Bird-to-human transmission of avian influenza is rare, with only a small number of cases previously recorded in the UK.

 

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less